BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34206794)

  • 1.
    Morena F; Argentati C; Tortorella I; Emiliani C; Martino S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M
    Ibrahim MAA; Abdelrahman AHM; Mohamed TA; Atia MAM; Al-Hammady MAM; Abdeljawaad KAA; Elkady EM; Moustafa MF; Alrumaihi F; Allemailem KS; El-Seedi HR; Paré PW; Efferth T; Hegazy MF
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
    Cui J; Jia J
    Eur J Med Chem; 2021 Dec; 225():113789. PubMed ID: 34438124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity.
    Weng YL; Naik SR; Dingelstad N; Lugo MR; Kalyaanamoorthy S; Ganesan A
    Sci Rep; 2021 Apr; 11(1):7429. PubMed ID: 33795718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
    Saify Nabiabad H; Amini M; Demirdas S
    Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.
    Kavitha K; Sivakumar S; Ramesh B
    Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein.
    Lin YC; Chen WY; Hwu ET; Hu WP
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals.
    Sun LY; Chen C; Su J; Li JQ; Jiang Z; Gao H; Chigan JZ; Ding HH; Zhai L; Yang KW
    Bioorg Chem; 2021 Jul; 112():104889. PubMed ID: 33915460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
    Mironov V; Shchugoreva IA; Artyushenko PV; Morozov D; Borbone N; Oliviero G; Zamay TN; Moryachkov RV; Kolovskaya OS; Lukyanenko KA; Song Y; Merkuleva IA; Zabluda VN; Peters G; Koroleva LS; Veprintsev DV; Glazyrin YE; Volosnikova EA; Belenkaya SV; Esina TI; Isaeva AA; Nesmeyanova VS; Shanshin DV; Berlina AN; Komova NS; Svetlichnyi VA; Silnikov VN; Shcherbakov DN; Zamay GS; Zamay SS; Smolyarova T; Tikhonova EP; Chen KH; Jeng US; Condorelli G; de Franciscis V; Groenhof G; Yang C; Moskovsky AA; Fedorov DG; Tomilin FN; Tan W; Alexeev Y; Berezovski MV; Kichkailo AS
    Chemistry; 2022 Feb; 28(12):e202104481. PubMed ID: 35025110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M
    Mangiavacchi F; Botwina P; Menichetti E; Bagnoli L; Rosati O; Marini F; Fonseca SF; Abenante L; Alves D; Dabrowska A; Kula-Pacurar A; Ortega-Alarcon D; Jimenez-Alesanco A; Ceballos-Laita L; Vega S; Rizzuti B; Abian O; Lenardão EJ; Velazquez-Campoy A; Pyrc K; Sancineto L; Santi C
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
    Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
    Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
    Ghosh A; Chakraborty M; Chandra A; Alam MP
    J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M
    Bissaro M; Bolcato G; Pavan M; Bassani D; Sturlese M; Moro S
    ChemMedChem; 2021 Jul; 16(13):2075-2081. PubMed ID: 33797868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Phytochemicals Derived from
    Mahmud S; Paul GK; Afroze M; Islam S; Gupt SBR; Razu MH; Biswas S; Zaman S; Uddin MS; Khan M; Cacciola NA; Emran TB; Saleh MA; Capasso R; Simal-Gandara J
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanism of Interaction between DNA Aptamer and Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Revealed by Steered Molecular Dynamics Simulations.
    Ding X; Xu C; Zheng B; Yu H; Zheng P
    Molecules; 2024 May; 29(10):. PubMed ID: 38792076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation.
    Di Micco S; Musella S; Sala M; Scala MC; Andrei G; Snoeck R; Bifulco G; Campiglia P; Fasano A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Hydroxyethylamine Analogs against 3CL
    Kumar S; Sharma PP; Shankar U; Kumar D; Joshi SK; Pena L; Durvasula R; Kumar A; Kempaiah P; Poonam ; Rathi B
    J Chem Inf Model; 2020 Dec; 60(12):5754-5770. PubMed ID: 32551639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.